Rexulti
NDC 59148-038, brexpiprazole, tablet, from Otsuka America Pharmaceutical, Inc..
- Product NDC
- 59148-038
- Status
- Listed
- Labeler
- Otsuka America Pharmaceutical, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205422
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59148-038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BREXPIPRAZOLE2 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59148-038-07 | 59148003807 | 1 BLISTER PACK in 1 CARTON (59148-038-07) / 7 TABLET in 1 BLISTER PACK |
| 59148-038-13 | 59148003813 | 1 BOTTLE in 1 CARTON (59148-038-13) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2d301358-6291-4ec1-bd87-37b4ad9bd850NADAC price for package 59148003813
GET /v1/drugs/nadac/59148003813
Use it
Look up 59148-038 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59148-038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59148-038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.